Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Xi-17-Methyloctadecanoic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004133 AN006853 Metabolite profiling of portal and cardiac puncture plasma in C57Bl6 mice treated with Vancomycin or Metronidazole under a regular or high fat diet. Blood Mouse Diabetes Broad Institute of MIT and Harvard LC-MS
ST004132 AN006849 Metabolite profiling of portal plasma, cardiac puncture plasma, and cecal contents of 129 T, 129 J, C57Bl6 mice. Blood Mouse Diabetes Broad Institute of MIT and Harvard LC-MS
ST004132 AN006849 Metabolite profiling of portal plasma, cardiac puncture plasma, and cecal contents of 129 T, 129 J, C57Bl6 mice. Cecal content Mouse Diabetes Broad Institute of MIT and Harvard LC-MS
ST004093 AN006786 Autoimmune Disease Risk Gene ANKRD55 Promotes T Cell Proliferation and Th17 2 Effector Function Through Metabolic Modulation T-cells Mouse Autoimmune disease Broad Institute of MIT and Harvard LC-MS
ST003786 AN006221 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis Feces Human Colitis Broad Institute of MIT and Harvard LC-MS
ST003438 AN005652 Unbiased genetic screening and metabolomics identifies glial adenosine metabolism as a therapeutic target in Parkinson’s disease Fly Head Fruit fly Parkinsons disease Broad Institute of MIT and Harvard LC-MS
ST002820 AN004596 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center Other
ST002819 AN004592 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center Other
ST002536 AN004174 Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma Thyroid Human Cancer Broad Institute of MIT and Harvard LC-MS
ST002471 AN004036 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling Feces Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002470 AN004032 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling Blood Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002246 AN003669 Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study Feces Human Broad Institute of MIT and Harvard LC-MS
ST002018 AN003288 Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) Feces Human Vanderbilt University Medical Center LC-MS
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center LC-MS
ST001983 AN003234 Metabolomic Fingerprinting of Human High Grade Serous Ovarian Carcinoma Cell Lines Ovarian cancer cells Human Cancer University of Oklahoma Health Sciences Center LC-MS
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001866 AN003028 Systemic metabolite changes due to PHD inhibition Blood Mouse Northwestern University LC-MS
ST001865 AN003025 Systemic metabolite changes due to Hypoxia Blood Mouse Northwestern University LC-MS
ST001521 AN002536 Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) Blood Human Broad Institute of MIT and Harvard LC-MS
ST001519 AN002528 Stool metabolites of known identity profiled using hybrid nontargeted methods (part-I) Feces Human Broad Institute of MIT and Harvard LC-MS
ST001404 AN002346 Ontogeny related changes in the pediatric liver metabolome (part-III) Liver Human Moffitt Cancer Center LC-MS
ST001403 AN002345 Ontogeny related changes in the pediatric liver metabolome (part-II) Liver Human Moffitt Cancer Center LC-MS
ST001253 AN002081 Phenotyping Mouse blood metabolites in day and night in type 2 diabetes Blood Mouse Diabetes Indiana University School of Medicine LC-MS
ST001212 AN002046 Fish-oil supplementation in pregnancy, child metabolomics and asthma risk Blood Human University of Copenhagen LC-MS
ST001192 AN001986 A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research Feces Human Broad Institute of MIT and Harvard LC-MS
ST001153 AN001903 Erythrocyte adenosine A2B receptor-mediated AMPK activation: Counteracting CKD by promoting oxygen delivery Blood Mouse Kidney disease University of Texas Health Science Center at Houston GC-MS
ST001144 AN001887 Microbial depletion and ozone exposure - serum (part II) Blood Mouse Asthma Harvard School of Public Health GC-MS/LC-MS
ST001143 AN001883 Microbial depletion and ozone exposure - Lung tissue (part I) Lung Mouse Asthma Harvard School of Public Health GC-MS/LC-MS
ST000976 AN001597 GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) Blood Human Tuberculosis Max Planck Institute for Infection Biology LC-MS
ST000975 AN001596 GC6-74 metabolomics of TB vs healthy (Part 2: Serum) Blood Human Tuberculosis Max Planck Institute for Infection Biology LC-MS
ST000974 AN001595 GC6-74 matabolomic of TB (Part 1: Plasma) Blood Human Tuberculosis Max Planck Institute for Infection Biology LC-MS
ST000930 AN001524 Define alterations in the gut metabolome of mice infected with C. difficile Cecum Mouse North Carolina State University LC-MS
ST000923 AN001515 Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease Feces Human Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST000899 AN001464 Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling Blood Human Inflammatory bowel disease Vanderbilt University Medical Center LC-MS
ST000815 AN001292 db/db WT ozone and air exposed mice Lung Mouse Ozone Stress Harvard School of Public Health GC-MS/LC-MS
ST000452 AN000708 The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data Blood Mouse University of North Carolina at Chapel Hill GC-MS
ST000451 AN000707 The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data Muscle Mouse University of North Carolina at Chapel Hill GC-MS
ST000093 AN000149 Metabolomics Analysis of Frontal Fibrosing Alopecia Scalp Human Alopecia Case Western Reserve University GC-MS/LC-MS
  logo